FDA approves FebriDx POC test

FebriDx is designed to help identify whether an acute respiratory infection is likely caused by bacteria or by a non-bacterial cause, using a simple finger-prick blood sample.

This information can support doctors when making treatment decisions, especially in emergency rooms and urgent care clinics. The test is used together with a patient’s symptoms, medical history, and other laboratory results to provide a better overall assessment.

With FDA clearance, FebriDx is now available for use by healthcare professionals in the United States, expanding access to rapid diagnostic testing and supporting better patient care.

FebriDx